Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877716 · ClinicalTrials.gov registry record · NA
EPI-MINN: Targeting Cognition and Motivation - National
A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by University of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05877716 is a NA study of Schizophrenia and Schizoaffective Disorder that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 200 participants, roughly in line with the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05877716, a NA study of Schizophrenia and Schizoaffective Disorder, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. We will recruit participants who are receiving care for early psychosis from clinics across the United States. We will compare outcomes from participants who receive treatment at coordinated specialty care (CSC) early psychosis clinics to those that receive standard community care. A qualifying CSC program will provide comprehensive clinical services such as psychotherapy, medication management, psychoeducation, and work or education support. This study will be conducted remotely, and participants can participate at home with their own electronic devices. The aim of this study is to investigate a well-defined 12-week mobile intervention program specifically designed to target cognitive functioning and motivated behavior for individuals with early psychosis. Participants will complete a screening interview which will include diagnosis and symptom ratings, neurocognitive assessment, and self-reports of symptoms, behavior, and functioning. Then participants will be randomized to receive the 12-week mobile intervention, or an active control of treatment as usual. The investigators will test for differences in the clinical trajectories after training, and at two follow up appointments at 6 and 12 months post-training.
Conditions Studied
Interventions
- DEVICE Cognitive and Social Cognitive Training
- BEHAVIORAL Personalized Real-Time Intervention for Motivational Enhancement (PRIME) App
- OTHER Early Psychosis Coordinated Specialty Care
Study Locations (1)
Minnesota
- University of Minnesota Department of Psychiatry & Behavioral Sciences - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05877716
The ClinicalTrials.gov registry entry for NCT05877716 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Schizophrenia appearing as the primary indexed condition, and to 3 interventions - of which Cognitive and Social Cognitive Training is the first listed.
NCT05877716 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05877716 about?
NCT05877716 is a clinical study titled "EPI-MINN: Targeting Cognition and Motivation - National". The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. We will recruit participants who...
What is the current status of trial NCT05877716?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-05-30. Estimated completion is 2026-06-30.
What conditions does trial NCT05877716 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder, Psychosis, Schizo Affective Disorder, Schizophreniform Disorders.
What interventions are being tested in trial NCT05877716?
The interventions under investigation include: Cognitive and Social Cognitive Training (DEVICE), Personalized Real-Time Intervention for Motivational Enhancement (PRIME) App (BEHAVIORAL), Early Psychosis Coordinated Specialty Care (OTHER).
Who is sponsoring clinical trial NCT05877716?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05877716 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.